Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus

被引:97
作者
O'Neill, AJ
Cove, JH
Chopra, I [1 ]
机构
[1] Univ Leeds, Antimicrobial Res Ctr, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Div Microbiol, Leeds LS2 9JT, W Yorkshire, England
关键词
D O I
10.1093/jac/47.5.647
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Frequencies at which mutants resistant to fusidic acid and/or rifampicin arose in vitro were determined in Staphylococcus aureus strains including methicillin-susceptible S. aureus (MSSA), methicillin-resistant S, aureus (MRSA), vancomycin-intermediate resistant S. aureus (VISA) and hetero-VISA. The concentrations of fusidic acid (30 and 15 mg/L) and rifampicin (16 acid 1 mg/L) used for selection were equal to the expected maximum and minimum serum concentrations after an oral regimen of rifampicin 900 mg od, together with fusidic acid 500 mg tds, Resistant mutants arose at a frequency of around 10(-8) for selections with rifampicin, but were undetectable (frequency < 10(-11)) for selections with fusidic acid. Mutants were not recovered (frequency < 10(-11)) after selections in the presence of both fusidic acid and rifampicin at 30/16 and 15/1 mg/L, Our results suggest that these antibiotics, when used in combination, could have a wider role in the management of staphylococcal infections.
引用
收藏
页码:647 / 650
页数:4
相关论文
共 10 条
[1]   Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997 [J].
Andrews, J ;
Ashby, J ;
Jevons, G ;
Lines, N ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :689-698
[2]  
[Anonymous], USE ANTIBIOTICS
[3]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[4]   Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin [J].
Drancourt, M ;
Stein, A ;
Argenson, JN ;
Roiron, R ;
Groulier, P ;
Raoult, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :235-240
[5]  
Eisenstadt Eric, 1994, P297
[6]   Vancomycin resistance in Staphylococci [J].
Hiramatsu, K .
DRUG RESISTANCE UPDATES, 1998, 1 (02) :135-150
[7]  
Howe RA, 1998, LANCET, V351, P602, DOI 10.1016/S0140-6736(05)78597-4
[8]   Mutation frequencies and antibiotic resistance [J].
Martinez, JL ;
Baquero, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1771-1777
[9]   RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus [J].
O'Neill, A ;
Oliva, B ;
Storey, C ;
Hoyle, A ;
Fishwick, C ;
Chopra, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3163-3166
[10]   Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides [J].
Tenover, FC ;
Lancaster, MV ;
Hill, BC ;
Steward, CD ;
Stocker, SA ;
Hancock, GA ;
O'Hara, CM ;
Clark, NC ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) :1020-1027